|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2014. Ann Oncol. 25:1650–1656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sohal DP, Mangu PB, Khorana AA, Shah MA,
Philip PA, O'Reilly EM, Uronis HE, Ramanathan RK, Crane CH,
Engebretson A, et al: Metastatic pancreatic cancer: American
Society of clinical oncology clinical practice guideline. J Clin
Oncol. 34:2784–2796. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hurwitz HI, Uppal N, Wagner SA, Bendell
JC, Beck JT, Wade SM III, Nemunaitis JJ, Stella PJ, Pipas JM,
Wainberg ZA, et al: Randomized, double-blind, phase II study of
ruxolitinib or placebo in combination with capecitabine in patients
with metastatic pancreatic cancer for whom therapy with gemcitabine
has failed. J Clin Oncol. 33:4039–4047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amano M, Fukata Y and Kaibuchi K:
Regulation and functions of Rho-associated kinase. Exp Cell Res.
261:44–51. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lochhead PA, Wickman G, Mezna M, Mezna M
and Olson MF: Activating ROCK1 somatic mutations in human cancer.
Oncogene. 29:2591–2598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gilkes DM, Xiang L, Lee SJ, Chaturvedi P,
Hubbi ME, Wirtz D and Semenza GL: Hypoxia-inducible factors mediate
coordinated RhoA-ROCK1 expression and signaling in breast cancer
cells. Proc Natl Acad Sci USA. 111:E384–E393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rath N and Olson MF: Rho-associated
kinases in tumorigenesis: Re-considering ROCK inhibition for cancer
therapy. EMBO Rep. 13:900–908. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumuor Biol. 36:7615–7622.
2015. View Article : Google Scholar
|
|
13
|
Peng W and Fan H: Long noncoding RNA CCHE1
indicates a poor prognosis of hepatocellular carcinoma and promotes
carcinogenesis via activation of the ERK/MAPK pathway. Biomed
Pharmacother. 83:450–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kamarajah SK, Burns WR, Frankel TL, Cho CS
and Nathan H: Validation of the American Joint Commission on Cancer
(AJCC) staging system for patients with pancreatic adenocarcinoma:
A surveillance, epidemiology and end results (SEER) analysis. Ann
Surg Oncol. 24:2023–2030. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chisholm KM, Wan Y, Li R, Montgomery KD,
Chang HY and West RB: Detection of long non-coding RNA in archival
tissue: Correlation with polycomb protein expression in primary and
metastatic breast carcinoma. PLoS One. 7:E479982012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL and
Der CJ: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shields MA, Krantz SB, Bentrem DJ,
Dangi-Garimella S and Munshi HG: Interplay between β1-integrin and
Rho signaling regulates differential scattering and motility of
pancreatic cancer cells by snail and Slug proteins. J Biol Chem.
287:6218–6229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang H, Zhang M and Sun G: Long non-coding
RNA NEAT1 regulates the proliferation, migration and invasion of
gastric cancer cells via targeting miR-335-5p/ROCK1 axis.
Pharmazie. 73:150–155. 2018.PubMed/NCBI
|
